Everything below concerns freeze-thaw. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Container and environment choices matter. Peptides may adsorb to glass, plastic, or filter membranes, especially at low concentrations. Low-binding tubes and inert containers reduce loss. Moisture barriers include sealed bags with desiccant, and light protection uses amber vials or opaque wraps. Inert gas blankets can limit oxidation for sequences containing methionine, cysteine, or tryptophan. Buffers and pH also affect solution stability; extremes of pH accelerate hydrolysis and deamidation. These practices apply to research and manufacturing settings, not to any specific clinical use.
Peptides are short amino acid polymers whose stability depends on sequence, length, and chemical modifications. In dry form, most peptides are relatively stable because low water activity slows hydrolysis and other degradation. Residual moisture, oxygen, and light can still promote oxidation, deamidation, or aggregation over time. Storage recommendations therefore usually combine low temperature, desiccation, and protection from light. Because each peptide has distinct properties, no single condition fits every sequence.
Temperature selection balances degradation rate against physical changes. Many lyophilized peptides are stored at -20 °C, while some modified or longer sequences require -80 °C for extended periods. Aqueous stock solutions are less stable and are often kept at -20 °C or below in single-use aliquots. Repeated freeze-thaw cycles can cause aggregation, precipitation, or loss of activity, so aliquoting before freezing reduces that risk. Frost-free freezers cycle above freezing and may be unsuitable for long-term peptide storage.
Temperature is a primary factor in peptide storage. Lower temperatures reduce molecular motion and slow degradation reactions, but freezing can concentrate solutes and promote aggregation. Lyophilized powders are commonly held at -20°C, whereas solutions are often kept at -80°C. Repeated freeze-thaw cycles are harmful because ice crystal formation and pH shifts can damage the peptide. The glass transition temperature of a lyophilized cake influences its stability; below this temperature, molecular mobility is restricted. For solutions, the choice between -20°C and -80°C depends on the peptide's sensitivity and the intended storage duration.
Moisture, oxygen, and light also affect peptide integrity. Lyophilized powders absorb water from the air, which can enable hydrolysis and conformational changes. Oxygen promotes oxidation of sensitive residues, so storage under inert gas or in sealed vials is common. Light exposure can cause photodegradation, particularly for peptides containing aromatic amino acids. Buffer choice and pH influence charge state and solubility; extremes of pH accelerate deamidation and hydrolysis. Adding stabilizers such as sugars or polyols can protect the peptide during freezing and drying. Optimal conditions are determined empirically for each peptide.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized powder | Common shipping and storage form; hygroscopic after opening. |
| Typical storage temperature | -20 °C | Desiccated and protected from light; some sequences require -80 °C. |
| Solubility class | Sequence-dependent | Often soluble in water or dilute buffer; some require an organic modifier. |
| Moisture sensitivity | Moderate to high | Sealed containers with desiccant reduce hydrolysis and aggregation. |
| Light sensitivity | Variable | Amber vials or opaque wrapping limit photodegradation. |
Light exposure can damage aromatic residues and certain labels, so amber vials or opaque containers are often used. pH control matters in solution, as extreme acidity or alkalinity accelerates backbone cleavage; buffers may also introduce ions that affect solubility. Microbial growth is a concern for aqueous preparations that lack preservatives, though many research peptides are handled in sterile or low-bioburden conditions. Container materials can adsorb peptides, particularly hydrophobic or positively charged sequences, reducing recovery. These factors interact, meaning storage decisions balance chemical stability, physical state, and intended use.
Peptides are short chains of amino acids whose physical and chemical stability depends on sequence, length, and conformation. The amide backbone can hydrolyze under acidic or basic conditions, while side chains such as methionine, cysteine, and tryptophan are prone to oxidation. Aggregation may occur when hydrophobic regions associate, especially near surfaces or at high concentration. Because these pathways differ among peptides, no single storage condition applies to all sequences. Stability studies therefore examine each peptide under defined temperature, pH, and humidity ranges.
Light, oxygen, and pH influence peptide integrity through specific side-chain reactions. Methionine and cysteine residues are susceptible to oxidation, and tryptophan can degrade under strong light. Inert gas overlays and amber glass or opaque containers reduce these risks. pH affects charge, solubility, and the rate of deamidation or aggregation; a value that minimizes one pathway may increase another. The optimal pH and buffer for a given peptide are often determined experimentally, and open questions remain about predicting stability from sequence alone.
Peptides are short chains of amino acids linked by amide bonds, and their storage stability depends on sequence, length, and three-dimensional structure. Chemical degradation can occur through hydrolysis, oxidation, deamidation, and aggregation, while physical changes such as precipitation or surface adsorption reduce recovery. Storage conditions are chosen to slow these processes without altering the peptide itself. Because peptides vary widely, no single condition suits every sequence, so laboratories often establish stability empirically for each batch.
The cell-mediated response to the virus and to vectors is poorly characterised, and has been largely ignored in the literature as recently as 2005. Clinical trials using an AAV2-based vector to treat haemophilia B seem to indicate that targeted destruction of transduced cells may be occurring. Combined with data that shows that CD8+ T-cells can recognise elements of the AAV capsid in vitro, it appears that there may be a cytotoxic T lymphocyte response to AAV vectors. Cytotoxic responses would imply the involvement of CD4+ T helper cells in the response to AAV and in vitro data from human studies suggests that the virus may indeed induce such responses, including both Th1 and Th2 memory responses. A number of candidate T cell stimulating epitopes have been identified within the AAV capsid protein VP1, which may be attractive targets for modification of the capsid if the virus is to be used as a vector for gene therapy. There are several steps in the AAV infection cycle, from infecting a cell to producing new infectious particles:
BioLegend was founded by CEO, Gene Lay, D.V.M., who was also the co-founder of PharMingen. In 2011, BioLegend co-developed and introduced Brilliant Violet(TM)-conjugated antibodies, using a novel fluorophore based on Nobel Prize-winning chemistry developed by Sirigen. In 2018, BioLegend introduced TotalSeq™ antibody-oligonucleotide conjugates for use in single cell proteogenomics analysis. BioLegend continued expansion and moved into a new 8-acre campus at BioLegend Way in 2019 with state of the art facilities designed to accommodate up to 1000 employees.
{\displaystyle {\begin{array}{l}{}\\{\ce {^{232}_{90}Th->[\alpha ][1.40\times 10^{10}\ {\ce {y}}]{^{228}_{88}Ra}->[\beta ^{-}][5.75\ {\ce {y}}]{^{228}_{89}Ac}->[\beta ^{-}][6.15\ {\ce {h}}]{^{228}_{90}Th}->[\alpha ][1.9125\ {\ce {y}}]{^{224}_{88}Ra}->[\alpha ][3.632\ {\ce {d}}]{^{220}_{86}Rn}}}\\{\ce {^{220}_{86}Rn->[\alpha ][55.6\ {\ce {s}}]{^{216}_{84}Po}->[\alpha ][144.0\ {\ce {m}}s]{^{212}_{82}Pb}->[\beta ^{-}][10.627\ {\ce {h}}]{^{212}_{83}Bi}}}{\begin{Bmatrix}{\ce {->[64.06\%\beta ^{-}][60.55\ {\ce {min}}]{^{212}_{84}Po}->[\alpha ][294.4\ {\ce {ns}}]}}\\{\ce {->[35.94\%\alpha ][60.55\ {\ce {min}}]{^{208}_{81}Tl}->[\beta ^{-}][3.053\ {\ce {min}}]}}\end{Bmatrix}}{\ce {^{208}_{82}Pb}}\end{array}}}
=== Available forms === Nabiximols (brand name Sativex), an oromucosal spray made of a complex botanical mixture containing cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC), and additional cannabinoid and non-cannabinoid constituents from cannabis sativa plants, was approved by Health Canada in 2005, to treat central neuropathic pain in multiple sclerosis, and in 2007, for cancer-related pain. In New Zealand, Sativex is "approved for use as an add-on treatment for symptom improvement in people with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication." Epidiolex (Epidyolex in Europe) is an orally administered cannabidiol solution. It was approved in 2018 for treatment of two rare forms of childhood epilepsy, Lennox–Gastaut syndrome and Dravet syndrome, and seizures associated with tuberous sclerosis complex. In the US, it is approved in these indications for people one year of age and older.
Sources: en.wikipedia.org
=== Brewing fresh leaves === To prepare mint tea from fresh leaves, the leaves are harvested, washed, and placed in boiling water for a few minutes. While fresh and dried leaves have similar flavors, some studies suggest that tea brewed with fresh leaves produces a fresher, more aromatic experience.
== History of drug delivery == Drug delivery is a process of administering therapeutics to treat human diseases. The first drug delivery system is often dated to the 1950s, when Smith Kline & French Laboratories introduced the Spansule technology. Between 1950s and 1980s, there were four drug release systems developed for oral and transdermal applications: dissolution, diffusion, osmosis, and ion-exchange controlled release. Later in the 1980s, the Lupron Depot technology further advanced the field by offering zero-order and long-term release systems. The intranasal route gained interest towards the end of the 20th century with treating cardiovascular and respiratory diseases. During the late 1980s, William Frey II studied the intranasal route for treating brain diseases. Ever since, it has become a potential route for nose-to-brain delivery.
Syringomycin E is a member of a class of lipodepsinonapeptide molecules that are secreted by the plant pathogen Pseudomonas syringae. Lipodepsinonapeptides comprise a closed ring of nine nonribosomally synthesized amino acids bonded to a fatty acid hydrocarbon tail. A commonly encountered pathovar (pv) of P. syringae is P. syringae pv syringae, which secretes a number of closely related forms of the molecule. Syringomycins are virulence determinants, which means that their secretion is required for the manifestation of disease symptoms on a number of stone fruit crop plants. Syringomycins have two widely recognized mechanisms of action. They can function as detergents which are powerful enough to dissolve plant membranes at high concentrations. It is not clear whether concentrations high enough to dissolve membranes are ever reached in planta. In addition to being surfactants, aggregates of syringomycins can insert into plant cell membranes and form small pores. These pores allow the leakage of ions from the plant cell cytoplasm. Affected plant cells are unable to maintain their required levels of electrolyte and ultimately cell death and lysis occurs. It is believed that P. syringae benefits from the release of nutrients that occurs as a consequence of cellular lysis. The biosynthesis of this class of molecules has been elucidated.
==== Postoperative outcome ==== In some trigger finger patients, tenderness is found in the dorsal proximal interphalangeal (PIP) joint. Dorsal PIP joint tenderness is more common in trigger fingers than previously thought. It is also associated with higher and prolonged levels of postoperative pain after A1 pulley release. Therefore, patients with pre-existing PIP tenderness should be informed about the possibility of sustaining residual minor pain for up to 3 months after surgery.
==== Metabolism ==== Doxepin is extensively metabolized by the liver via oxidation and N-demethylation. Its metabolism is highly stereoselective. Based on in vitro research, the major enzymes involved in the metabolism of doxepin are the cytochrome P450 enzymes CYP2D6 and CYP2C19, with CYP1A2, CYP2C9, and CYP3A4 also involved to a lesser extent. The major active metabolite of doxepin, nordoxepin, is formed mainly by CYP2C19 (>50% contribution), while CYP1A2 and CYP2C9 are involved to a lesser extent, and CYP2D6 and CYP3A4 are not involved. Both doxepin and nordoxepin are hydroxylated mainly by CYP2D6, and both doxepin and nordoxepin are also transformed into glucuronide conjugates. The elimination half-life of doxepin is about 15–18 hours, whereas that of nordoxepin is around 28–31 hours. Up to 10% of Caucasian individuals show substantially reduced metabolism of doxepin that can result in up to 8-fold elevated plasma concentrations of the drug compared to normal. Nordoxepin is a mixture of (E) and (Z) stereoisomers similarly to doxepin. Whereas pharmaceutical doxepin is supplied in an approximate 85:15 ratio mixture of (E)- and (Z)-stereoisomers and plasma concentrations of doxepin remain roughly the same as this ratio with treatment, plasma levels of the (E)- and (Z)-stereoisomers of nordoxepin, due to stereoselective metabolism of doxepin by cytochrome P450 enzymes, are approximately 1:1.
Sources: en.wikipedia.org
A historian with a very strong work ethic, Peukert believed that history "belonged to everybody", not just the historians, and was very energetic in attempting to break down barriers to interest the public in history by settling up exhibitions about Alltagsgeschichte in the Third Reich. In 1980, Peukert planned the historical exhibition at the Old Synagogue of Essen on the subject "Resistance and Persecution in Essen 1933-1945". In 1984, Peukert won the Heinz Maier-Leibnitz Prize for his habilitation on youth policy in Germany in late 19th and early 20th centuries. Moving beyond the subject of resistance (Widerstand), Peukert became interested in "oppositionality" (Widerständigkeit) in everyday life in Nazi Germany. Peukert was especially interested in the Edelweiss Pirates, a group of working class teenagers in Cologne and the other cities of the Rhineland who formed a distinctive anti-Nazi subculture, and who often fought the Hitler Youth. Another related area of interest for Peukert was resistance, opposition and dissent in the Third Reich. Peukert developed a pyramid model starting with "nonconformity" (behavior in private that featured partial rejection of the Nazi regime) running to "refusal of co-operation" (Verweigerung) to "protest", and finally to Widerstand (resistance), which involved total rejection of the Nazi regime. In particular, Peukert looked at how in "everyday life" in Nazi Germany, aspects of both "normality" and "criminality" co-existed with another.
=== Lifestyle === According to a 2018 systematic review based on studies that implemented 8 to 14 week-long exercise programs, there is currently insufficient scientific evidence regarding either the beneficial or harmful effects of physical exercise in people with cirrhosis on all-cause mortality, morbidity (including both serious and non-serious adverse events), health-related quality of life, exercise capacity and anthropomorphic measures. These conclusions were based on low to very low quality research, which imposes the need to develop further research with higher quality, especially to evaluate its effects on clinical outcomes.
Aluminium potassium sulfate: White Copper(II) sulfate: Blue Chromium(III) chloride: Green Nickel(II) sulfate: Green Iron(II) sulfate: Green Iron(III) chloride: Orange Cobalt(II) chloride: Purple Calcium chloride: White Zinc sulfate: White Manganese(II) chloride: Pink
=== March === 1 March 35-year-old Marcus Osborne is given a whole life order, the most severe possible sentence available in England and Wales, for the "sadistic" murders of Steven Harnett and Katie Higton. He receives a further 10-year sentence for the rape and false imprisonment of another woman who was present at the scene, who cannot be named for legal reasons. 29-year-old Joshua Jacques is sentenced to a minimum of 46 years in prison for murdering his girlfriend and three of her family members in a "sacrifice" at their home in Bermondsey, south London, in April 2022. The Met Office reports that England and Wales had their warmest February on record this year, with an average of 7.5 °C recorded for England and 6.9 °C for Wales. Scientists at the Centre for Environment, Fisheries and Aquaculture Science announce the discovery of a new species of sea slug off the southwest coast of England. 2 March The 2024 BRIT Awards take place. Northumberland National Park announces that the Sycamore Gap tree which was illegally felled last September is to go on public display. 4 March The Princess of Wales is photographed for the first time since her surgery, with US celebrity news site TMZ publishing a photo of the princess riding as a passenger in a car being driven by her mother near Windsor Castle. Rumours and conspiracy theories over Catherine's whereabouts have surfaced in recent weeks as she hasn't been seen in public since late December. Cadbury celebrate their 200th anniversary.
The ocular complications of MFS can often be treated with surgery. Ectopia lentis can be treated, as artificial lenses can be surgically implanted. In addition, surgery can address glaucoma, retinal detachment or tears, and cataracts. Treatment of a spontaneous pneumothorax is dependent on the volume of air in the pleural space and the natural progression of the individual's condition. A small pneumothorax might resolve without active treatment in one to two weeks. Recurrent pneumothoraces might require chest surgery. Moderately sized pneumothoraces might need chest drain management for several days in a hospital. Large pneumothoraces are likely to be medical emergencies requiring emergency decompression. As an alternative approach, custom-built supports for the aortic root are also being used. As of 2020 this procedure has been used in over 300 people with the first case occurring in 2004.
Sources: en.wikipedia.org
Dry powders have low water activity, which slows hydrolysis and many chemical degradation routes. Solutions provide mobility and water for reactions, so they typically degrade faster even when refrigerated. Lyophilization itself does not make a peptide immune to oxidation or moisture uptake.
No. Many lyophilized peptides remain suitable at -20 °C for routine periods, while some sequences or modified products may need colder storage. The optimal condition depends on sequence, formulation, expected duration, and supplier data. Stability testing, not assumption, establishes the appropriate condition.
Repeated freezing and thawing can concentrate solutes, promote aggregation, and cause precipitation or adsorption losses. Preparing single-use aliquots limits the number of cycles a given portion experiences. Some peptides tolerate cycling better than others, so empirical stability data are useful.
Removing water reduces hydrolytic degradation and limits microbial growth. Lyophilized powders are generally more stable at higher temperatures than aqueous solutions. They also tolerate shipping with less risk of degradation.